Follow this link to a listing of SEER SINQ's that have been finalized during the months of March and April 2023.
Highlights of this listing include:
20230016 instructs how to properly code histology for an anaplastic glioneuronal tumor, BRAF p.V600E mutant, WHO Grade III.
20230014 advises whether a case with thyroid FNA cytology of nodule 1 Bethesda Category 5 and nodule 2 Bethesda Category 6 would be reportable.
20230009 informs how many primaries are to be accessioned when a 2023 diagnosis of keratinizing squamous cell carcinoma (8071/3) of the vulva follows a previous diagnosis of nonkeratinizing squamous cell carcinoma (8072/3) of the vulva and the time rule (M12) does not apply.
